| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.008 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |